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ABSTRACT 
  
PHARMACEUTICAL CARE IMPLEMENTATION OF ANTIPSYCHOTICS 
THERAPY FOR SCHIZOPHRENIC PATIENTS TO THE QUALITY OF LIFE 
BASED ON PANSS SCORE AND ACTUAL DRUG RELATED PROBLEMS 
(Study at Mental Hospital Dr. Radjiman Wediodiningrat Lawang) 
  
  
Dwi Agustiningsih 
  
Schizophrenia is one of severe mental illnes that is caused by disturbances in 
dopaminergic system. Antipsychotics are used as the main pharmacological agents in the 
treatment of schizophrenia. PANSS is usually used to asses the condition of schizophrenic 
patients and their responses to the therapy. As it is a chronic illness, it need a long time 
therapy, so that Drug Related Problems (DRPs) may occur related to the compliance of the 
patients and the adverse reactions of the therapy. Pharmaceutical care in psychiatry is needed 
to identify and solve DRPs in order to reach the expected outcomes of therapy.  The aim of 
this study was to analyze the effects of pharmaceutical care in antipsychotics treatment for 
schizophrenic patients based on their changes in PANSS and identified DRPs. 
A prospective observational method was conducted in this study. It was approved by 
the Health Researches Ethics Committee of Faculty of Medicine of Airlangga University 
Surabaya. Data was collected from July to October 2018 involving 116 patients who have age 
of 31-40 years old in majority. Schizophrenic patients who have admitted to stable rooms for 
20 days were assesed for their PANSS and data about DRPs collected based on medical 
records. For 20 days later, there were pharmaceutical care implementation to identify and 
solve the actual DRPs, then PANSS assesed in the end of this section. PANSS before and 
after the implementation of pharmaceutical care were statistically analyzed by Wilcoxon test. 
PCNE V8.02 were used to analyze the DRPs identified along implementation of 
pharmaceutical care. 
The result showed that total PANSS score significantly decreased (from  58.84 ± 14.82 
to 48.09 ± 13.20; p < 0.05). Sixty three DRPs were identified before implementation of 
pharmaceutical care and 67 DRPs were found along implementation of pharmaceutical care. 
Seventy four causes of DRPs were identified and 344 intervenstions of pharmacist suggested, 
87% accepted and totally applied. The outcomes of pharmacist interventions showed that 
there were 1% totally solved DRP, 90% partially solved DRPs, and 9% unsolved DRPs.  
It could be concluded that implementation of pharmaceutical care may contribute to 
improve the quality of live of schizophrenic patients, so it has to be done continuously. The 
next studies are needed to asses the effect of pharmaceutical care implementation in 
schizophrenic outpatients. 
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